Literature DB >> 11496939

Effect of bilayer distruption on transdermal transport of low-molecular weight hydrophobic solutes.

S Mitragotri1.   

Abstract

PURPOSE: Applications of transdermal drug delivery are limited by low skin permeability. Several chemicals have been used to enhance transdermal drug transport, many of which enhance skin permeability by disordering lipid bilayers. The objective of this study was to develop a mathematical model to describe the effect of bilayer disrupting agents on skin permeability to low molecular weight hydrophobic drugs.
METHODS: I predicted solute partition and diffusion coefficients in the lipid bilayers of the stratum corneum using scaled particle theory, which calculates these coefficients based on the work required to create a cavity to incorporate the solute in the lipid bilayer.
RESULTS: Model equations predicted that no significant permeability enhancement would be observed for small solutes (MW < 100). Thereafter, the enhancement, E, increases with solute cross-sectional area. The resulting equation to predict the enhancement of skin permeability is given by E = exp[alpha(r2 - 8.7)], where r is solute molecular radius in angstroms and alpha is the degree of bilayer disorder. Predictions of the model were compared with the experimental data collected from several studies.
CONCLUSIONS: The model predictions compare well with the experimental data.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11496939     DOI: 10.1023/a:1010952731205

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  In situ determination of partition and diffusion coefficients in the lipid bilayers of stratum corneum.

Authors:  S Mitragotri
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

2.  Effects of transdermal penetration enhancers on the permeability of shed snakeskin.

Authors:  T Itoh; L Wasinger; T M Turunen; J H Rytting
Journal:  Pharm Res       Date:  1992-09       Impact factor: 4.200

3.  Sonophoresis. I. The use of high-frequency ultrasound to enhance transdermal drug delivery.

Authors:  D Bommannan; H Okuyama; P Stauffer; R H Guy
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

4.  An explanation for the variation of the sonophoretic transdermal transport enhancement from drug to drug.

Authors:  S Mitragotri; D Blankschtein; R Langer
Journal:  J Pharm Sci       Date:  1997-10       Impact factor: 3.534

5.  Evidence that oleic acid exists in a separate phase within stratum corneum lipids.

Authors:  B Ongpipattanakul; R R Burnette; R O Potts; M L Francoeur
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

6.  Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines.

Authors:  B J Aungst; J A Blake; M A Hussain
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

7.  A mechanistic study of ultrasonically-enhanced transdermal drug delivery.

Authors:  S Mitragotri; D A Edwards; D Blankschtein; R Langer
Journal:  J Pharm Sci       Date:  1995-06       Impact factor: 3.534

8.  A computer simulation of free-volume distributions and related structural properties in a model lipid bilayer.

Authors:  T X Xiang
Journal:  Biophys J       Date:  1993-09       Impact factor: 4.033

9.  Molecular distributions in interphases: statistical mechanical theory combined with molecular dynamics simulation of a model lipid bilayer.

Authors:  T X Xiang; B D Anderson
Journal:  Biophys J       Date:  1994-03       Impact factor: 4.033

10.  Effect of ultrasound on transdermal drug delivery to rats and guinea pigs.

Authors:  D Levy; J Kost; Y Meshulam; R Langer
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

View more
  1 in total

1.  Interactions of inertial cavitation bubbles with stratum corneum lipid bilayers during low-frequency sonophoresis.

Authors:  Ahmet Tezel; Samir Mitragotri
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.